Tower Research Capital (TRC)’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,266
| Closed | -$41K | – | 6962 |
|
|
2022
Q2 | $41K | Buy |
1,266
+734
| +138% | +$23.2K | ﹤0.01% | 3093 |
|
|
2022
Q1 | $14K | Sell |
532
-1,307
| -71% | -$31.9K | ﹤0.01% | 3946 |
|
|
2021
Q4 | $44K | Sell |
1,839
-392
| -18% | -$9.68K | ﹤0.01% | 2875 |
|
|
2021
Q3 | $56K | Buy |
2,231
+1,194
| +115% | +$30.4K | ﹤0.01% | 2866 |
|
|
2021
Q2 | $27K | Sell |
1,037
-1,148
| -53% | -$31.2K | ﹤0.01% | 3626 |
|
|
2021
Q1 | $56K | Buy |
2,185
+695
| +47% | +$17.8K | ﹤0.01% | 3040 |
|
|
2020
Q4 | $30K | Sell |
1,490
-29,981
| -95% | -$587K | ﹤0.01% | 3581 |
|
|
2020
Q3 | $539K | Buy |
31,471
+27,330
| +660% | +$517K | 0.01% | 1599 |
|
|
2020
Q2 | $90K | Buy |
+4,141
| New | +$94.8K | ﹤0.01% | 2556 |
|
|
2019
Q4 | – | Sell |
-160
| Closed | -$5K | – | 4678 |
|
|
2019
Q3 | $5K | Sell |
160
-478
| -75% | -$13.9K | ﹤0.01% | 3364 |
|
|
2019
Q2 | $16K | Buy |
638
+229
| +56% | +$5.83K | ﹤0.01% | 2315 |
|
|
2019
Q1 | $10K | Buy |
+409
| New | +$12.2K | ﹤0.01% | 2700 |
|
|
2018
Q4 | – | Sell |
-86
| Closed | -$3K | – | 4553 |
|
|
2018
Q3 | $3K | Sell |
86
-5,046
| -98% | -$178K | ﹤0.01% | 3361 |
|
|
2018
Q2 | $177K | Buy |
5,132
+4,670
| +1,011% | +$164K | 0.01% | 1131 |
|
|
2018
Q1 | $16K | Sell |
462
-762
| -62% | -$24.1K | ﹤0.01% | 2286 |
|
|
2017
Q4 | $47K | Sell |
1,224
-5,527
| -82% | -$221K | 0.01% | 1383 |
|
|
2017
Q3 | $253K | Buy |
6,751
+6,210
| +1,148% | +$219K | 0.02% | 592 |
|
|
2017
Q2 | $20K | Buy |
+541
| New | +$19.5K | ﹤0.01% | 1229 |
|
|
2017
Q1 | – | Sell |
-851
| Closed | -$30K | – | 4179 |
|
|
2016
Q4 | $30K | Sell |
851
-2,476
| -74% | -$97.2K | ﹤0.01% | 1797 |
|
|
2016
Q3 | $131K | Buy |
3,327
+1,399
| +73% | +$55.8K | 0.01% | 690 |
|
|
2016
Q2 | $73K | Buy |
1,928
+1,867
| +3,061% | +$62.5K | 0.01% | 1309 |
|
|
2016
Q1 | $2K | Buy |
+61
| New | +$2.27K | ﹤0.01% | 3494 |
|
|
2015
Q3 | – | Sell |
-374
| Closed | -$16K | – | 5031 |
|
|
2015
Q2 | $16K | Sell |
374
-118
| -24% | -$4.7K | ﹤0.01% | 2307 |
|
|
2015
Q1 | $19K | Buy |
+492
| New | +$18.1K | ﹤0.01% | 2309 |
|
|
2014
Q3 | – | Sell |
-500
| Closed | -$13K | – | 5041 |
|
|
2014
Q2 | $13K | Buy |
500
+337
| +207% | +$8.33K | ﹤0.01% | 2168 |
|
|
2014
Q1 | $4K | Sell |
163
-1,933
| -92% | -$48.7K | ﹤0.01% | 3493 |
|
|
2013
Q4 | $47K | Buy |
2,096
+1,584
| +309% | +$30.6K | 0.01% | 1444 |
|
|
2013
Q3 | $7K | Buy |
+512
| New | +$6.85K | ﹤0.01% | 3479 |
|
Other funds holding NTUS
Tower Research Capital (TRC)'s NTUS Position: Q3 2022 in Review
Tower Research Capital (TRC) sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 1,266 shares — an estimated $41K sold.
Tower Research Capital (TRC) first reported a position in NTUS in Q3 2013 and held it in 28 quarters. The position peaked at $539K in Q3 2020. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Tower Research Capital (TRC) reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,266 Natus Medical Inc shares in Q3 2022, an estimated $41K.
- Tower Research Capital (TRC) first reported a position in Natus Medical Inc in Q3 2013 and held it in 28 quarters.
- Tower Research Capital (TRC)'s Natus Medical Inc position peaked at $539K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.